• Au, W.Y., Ma, S.K., Ooi, C., Liang, R. & Kwong, Y.L. (2000) CNS extramedullary relapse of acute promyelocytic leukemia after arsenic trioxide-induced remission. Journal of Clinical Oncology, 18, 34353437.
  • Dombret, H., Rousselot, P., Hermine, O., Fermand, J.P., Poupon, J., Daniel, M.T., Chomienne, C., Tibbi, A., Lebbe, G., Solbes-Latourette, S., Brouet, J.C., Varet, B. & Degos, L. (2000) Treatment of relapsing acute promyelocytic leukemia (APL) with arsenic trioxide (As2O3) ± all-trans retinoic acid (ATRA): the French As98 study. Blood, 96, Abstract 3578.
  • Gianni, M., Koken, M.H., Chelbi-Alix, M.K., Benoit, G., Lanotte, M., Chen, Z. & De Thé, H. (1998) Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic- resistant NB4 cells. Blood, 91, 43004310.
  • Head, D., Kopecky, K.J., Weick, J., Weick, J., Files, J.C., Ryan, D., Foucar, K., Montiel, M., Bickers, J., Fishleder, A., Miller, M., Spier, C., Hanson, C., Bitter, M., Braziel, R., Mills, G., Welborn, J., Williams, W., Hewlett, J., Willman, C. & Appelbaum, F.R. (1995) Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood, 86, 17171728.
  • Kwong, Y.L., Wong, K.F. & Chan, T.K. (1995) Trisomy 8 in acute promyelocytic leukaemia: an interphase study by fluorescence in situ hybridization. British Journal of Haematology, 90, 697700.
  • Kwong, Y.L., Au, W.Y., Chim, C.S., Pang, A., Suen, C. & Liang, R. (2001) Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia. Clinicopathological and molecular features of a pilot study. American Journal of Hematology, 66, 274279.
  • Lallemand-Breitenbach, V., Guillemin, M.C., Janin, A., Daniel, M.T., Degos, L., Kogan, S.C., Bishop, J.M. & De Thé, H. (1999) Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. Journal of Experimental Medicine, 189, 10431052.
  • Ma, J. (2000) Clinical analysis of As2O3 and ATRA in the treatment of acute premyelocytic leukemia (APL). Blood, 96, Abstract 3577.
  • Niu, C., Yan, H., YuT., Sun, H.P., Liu, J.X., Li, X.S., Wu, W., Zhang, F.Q., Chen, Y., Zhou, L., Li, J.M., Zeng, X.Y., Ou Yang, R.R., Yuan, M.M., Ren, M.Y., Gu, F.Y., Cao, Q., Gu, B.W., Su, X.Y., Chen, G.Q., Xiong, S.M., Zhang, T.D., Waxman, S., Wang, Z.Y., Chen, Z., Hu, J., Shen, Z.X. & Chen, S.J. (1999) Studies on treatment of acute promyelocytic leukemia with arsenic trioxide. remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood, 94, 33153324.
  • Rego, E.M., He, L.Z., Warrell, R.P., Wang, Z.G. & Pandolfi, P.P. (2000) Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Proceedings of the National Academy of Sciences of the United States of America, 97, 1017310178.
  • Shen, Z.X., Chen, G.Q., Ni, J.H., Li, X.S., Xiong, S.M., Qiu, Q.Y., Zhu, J., Tang, W., Sun, C.L., Yang, K.Q., Chen, Y., Zhou, L., Fang, Z.W., Wang, Y.T., Ma, J., Zhang, P., Zhang, T.D., Chen, S.J., Chen, Z. & Wang, Z.Y. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 33543360.
  • Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., Pandolfi, P.P. & Warrell, Jr, R.P. (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New England Journal of Medicine, 339, 13411348.